google-site-verification: googlec7193c3de77668c9.html

Researchers develop chimeric allergen receptors as a new immunotherapy approach for asthma

[
Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system’s response against leukemias and other cancers. In a study published in the Journal of Experimental Medicine (JEM), researchers in Switzerland have adapted this approach to suppress the immune system’s response to a common allergen, reducing or preventing asthma symptoms in mice. The technique could eventually be used to treat a wide variety of allergies in humans.


Source link

Advertisements
Views: 0

See also  Are you exercising at the wrong time? How your body clock can affect your workouts

Check Also

Public to be asked who should pay for social care as part of major review

The public will be asked who should receive social care and how it should be …

Research improving care for Aboriginal people with diabetes-related foot disease

[ A new Kimberley-based study is helping Aboriginal people living with diabetes-related foot disease (DFD) …

AI unlocks previously invisible cortical lesions in MS using legacy MRI scans

[ Credit: CC0 Public Domain One of the uncomfortable truths about multiple sclerosis is that …

Leave a Reply

Available for Amazon Prime